DuPont to Spin Off Nutrition & BioSciences, RMT N&B with IFF
On December 16, 2019, DuPont de Nemours Inc. (“DuPont”) (NYSE: DD) announced a definitive agreement to spin off its Nutrition & Biosciences (N&B) business, which will be acquired by International Flavors and Fragrances Inc. (“IFF”) (NYSE: IFF) in a Reverse Morris Trust (RMT) transaction. The transaction values the combined company at $45.4 billion on an enterprise value basis, reflecting a value of $26.2 billion for the N&B business based on IFF’s share price as of December 13, 2019. Under the terms of the agreement, DuPont shareholders will own 55.4% of the shares of the new company and existing IFF shareholders will own 44.6%. Upon completion of the transaction, DuPont will receive a one-time $7.3 billion special cash payment, subject to certain adjustments. The spin-off of the N&B business, which is expected to be tax-free to shareholders, is expected to be completed by the end of the first quarter of 2021.
The combination of IFF and N&B creates a global leader in high-value ingredients and solutions for global Food & Beverage, Home & Personal Care and Health & Wellness markets, with estimated 2019 pro forma revenue of approximately $11 billion and EBITDA of $2.6 billion (EBITDA margin of approximately 23%), excluding synergies. The combined company will have leadership positions across key Taste, Texture, Scent, Nutrition, Enzymes, Cultures, Soy Proteins and Probiotics categories. IFF expects to realize cost synergies of approximately $300 million on a run-rate basis by the end of the third year post-closing. In addition, the combined company targets over $400 million in run-rate revenue synergies, which would result in more than $175 million of EBITDA, driven by cross-selling opportunities and a broader customer base. Separately, IFF confirmed its 2019 full-year guidance for revenues of $5.15 billion- $5.25 billion, adjusted EPS of $4.85-$5.05 and adjusted EPS (excluding amortization) of $6.15-$6.35.
For DuPont, the spin-off of the N&B business is another step in the company’s complex restructuring following the breakup of chemical giant DowDuPont. As background, the current DuPont Inc. is the result of the spin-off Dow Inc. (NYSE: DOW) which took place in April of this year, followed by the spin-off of the agriculture business, Corteva Inc. (NYSE: CTVA) in June. The transaction underscores the consolidation of the food-flavoring industry, as growth appears to be slowing and flavor manufacturers struggle with volatile raw-materials prices. DuPont is also said to be exploring further refinement of the business—specifically a potential divestiture of its Transportation business. Following the spin-off of the N&B business, DuPont will remain a global leader in technology-based materials. The post-spin company will be comprised of three business segments: 1) Electronics & Imaging , which supplies materials to manufacture photovoltaics and solar cells; materials and printing systems to the advanced printing industry; and materials and solutions for the fabrication of semiconductors and integrated circuits; 2) Transportation & Advanced Polymers, which manufactures engineering resins, adhesives, lubricants, and parts to engineers and designers in the transportation, electronics, healthcare, industrial, and consumer end-markets; and 3) Safety & Construction, which provides engineered products and integrated systems for construction, worker safety, energy, oil and gas, transportation, medical device, and water purification and separation industries.
PRELIMINARY VALUATION
In the companies’ current form, the N&B business, whose peers generally receive a premium valuation multiple versus specialty chemical peers, is being valued at a discount within DD’s larger structure. For its part IFF currently trades at 13.6x 2021 consensus EBITDA with peers averaging almost 17.5x 2021 consensus EBITDA while DD currently trades at 10.1x 2021 EBITDA. Anecdotally management did note that the acquisition price for the merger equates to about 18x EBITDA. We expect that IFF’s discount would narrow following the merger with N&B as the company exploits opportunities for revenue and cost synergies from the business combination as well as from the acquisition of Frutarom in late 2018. It is estimated that on a pro forma basis IFF would operate with an EBITDA margin of approximately 24% with opportunities to widen to 26% by the end of year three based on approximately $300 million in cost and $400 million in revenue synergies.
Following the separation, it can be estimated that IFF can grow revenue in the low-mid single digit range while expanding margins from the noted synergies. Estimating revenue of $12.9 billion in 2021 and EBITDA margins of 24.5%, the company would generate $3.2 billion in EBITDA in 2021. Assuming shares begin to receive a multiple closer to in line with peers of 15.0x (low end of peers), and post-merger net debt of $11.3 billion (includes $7.3 billion dividend to DD), and shares outstanding of 239.4 million (includes 132.6 million issued to DD shareholders), International Flavors and Fragrances would be fairly valued at $151 per share.
Absent N&B, DD would have generated approximately $16.4 billion in revenue in 2018. Through 3Q 2019 the company has seen year-over-year revenue declines in the mid-single digit range. Assuming a revenue decline of 7% in 2019, 3% in 2020 and flat in 2021, DD would generate sales of $14.8 billion in 2021. Assuming margins of 27% (roughly inline with where the company currently operates on a pro forma basis) DD ex-N&B would earn $4.0 billion before interest, taxes, depreciation, and amortization. Assuming DuPont’s multiple remains about the same at 10x, and accounting for post-spin net debt of $8.7 billion and shares outstanding of 740.8 million, post-spin shares of DD would be fairly valued at $42 per share. Incorporating the 55.4% ownership of post-merger IFF, pre-spin shares of DD are fairly valued at $69 per share.
Online Spin-Off Tracker: Real-Time Tracking of All Spin-Off Announcements, Form-10 Filings, and Recently Completed Spin-Offs, with market prices compared against The-Spin-Off Report’s fair value estimates to highlight investment opportunities.